E. Krognes - 31 Oct 2023 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John G. Saia, as attorney-in-fact for Steve Krognes
Issuer symbol
GH
Transactions as of
31 Oct 2023
Transactions value $
$0
Form type
4
Filing time
01 Nov 2023, 20:07:15 UTC
Previous filing
02 Oct 2023
Next filing
04 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $0 +154 +6.66% $0.00 2.47K 31 Oct 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -154 -3.02% $0.00 4.94K 31 Oct 2023 COMMON STOCK 154 $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a restricted stock unit award granted on August 9, 2022 that vests as to 25% of the shares subject to such award on June 30, 2023, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of June 30, 2023, during the three-year period thereafter.
F2 Not applicable for Restricted Stock Units.